AF
NVAX icon

Arrow Financial’s Novavax NVAX Stock Holding History

Arrow Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$724 – 359
2023
Q3 		$724 Hold
100
– – ﹤0.01% 338
2023
Q2 		$743 Hold
100
– – ﹤0.01% 317
2023
Q1 		$693 Hold
100
– – ﹤0.01% 318
2022
Q4 		$1K Hold
100
– – ﹤0.01% 328
2022
Q3 		$2K Hold
100
– – ﹤0.01% 328
2022
Q2 		$5K Hold
100
– – ﹤0.01% 320
2022
Q1 		$7K Hold
100
– – ﹤0.01% 310
2021
Q4 		$14K Hold
100
– – ﹤0.01% 274
2021
Q3 		$21K Hold
100
– – ﹤0.01% 259
2021
Q2 		$21K Hold
100
– – ﹤0.01% 261
2021
Q1 		$18K Hold
100
– – ﹤0.01% 267
2020
Q4 		$11K Buy
+100
New +$10.6K ﹤0.01% 269

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrow Financial's NVAX Position: Q4 2023 in Review

Arrow Financial sold out of Novavax (NVAX) in Q4 2023, closing a stake of 100 shares — an estimated $724 sold.

Arrow Financial first reported a position in NVAX in Q4 2020 and held it in 12 quarters. The position peaked at $21K in Q3 2021. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

  • Arrow Financial reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
  • Arrow Financial sold 100 Novavax shares in Q4 2023, an estimated $724.
  • Arrow Financial first reported a position in Novavax in Q4 2020 and held it in 12 quarters.
  • Arrow Financial's Novavax position peaked at $21K in Q3 2021.
  • 199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on Arrow Financial's 13F filing for Q4 2023, filed 12 Feb 2024.